Moderators:
Search This Board: 
Created: 04/26/2015 06:30:46 PM - Followers: 9 - Board type: Free - Posts Today: 0
Blueprint Medicines is a patient-driven oncology company developing highly selective kinase inhibitors for genomically defined cancer subsets. Led by a management team and advisors with world-renowned expertise in cancer genomics, drug discovery and clinical oncology, Blueprint has developed a platform that combines genomics with a novel library of kinase inhibitors, enabling Blueprint to rapidly develop potent highly selective compounds against clear genomic driver targets.
PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#16
BPMC buy 98.69 stocktrademan 09/12/2021 12:19:19 AM
#15 Blueprint Medicines Corp. TFMG 06/21/2020 02:15:20 PM
#14 Avapritinib Today is the date Frankestin 05/14/2020 06:35:40 AM
#13 Sold near EOD @ $59.60. Earnings pre-market tomorrow. chmcnfunds 07/31/2018 03:58:12 PM
#12 Back in @ $63.00. Chart not great. chmcnfunds 07/19/2018 10:28:08 AM
#11 Out @ $67.80. Has moved nicely with biotech chmcnfunds 07/06/2018 10:12:41 AM
#10 Back in @ $62 and $63. Still not chmcnfunds 06/25/2018 12:45:07 PM
#9 Out @ $73.60. May buy back if it chmcnfunds 06/13/2018 10:55:39 AM
#8 In at $68.50. Catalyst next week. chmcnfunds 06/07/2018 10:28:03 AM
#7 BPMC 8-k filed, published proof of concept data: north40000 04/16/2018 09:31:40 AM
#6 More than doubled over the last year. lugan 09/13/2017 01:59:50 PM
#5 BPMC bullish 20.36 stocktrademan 06/05/2016 12:43:36 PM
#4 Nice action since the lockup tpizzazz24 11/02/2015 03:27:40 PM
#3 Blueprint Medicines Corp's (BPMC) Lock-Up Period Set To protagonist12 10/21/2015 02:35:09 PM
#2 CAMBRIDGE, Mass., April 29, 2015 /PRNewswire/ -- Blueprint protagonist12 04/29/2015 08:33:57 PM
#1 Blueprint Medicines (BPMC) expects to raise $115 million protagonist12 04/26/2015 06:32:50 PM
Post Subject